Abstract
Optic nerve atrophy is a common neuro-ophthalmic problem. It represents the end result of either ascending degeneration after destruction of ganglion cells in the retina, or descending atrophy following destruction of nerve fibers in the optic nerve, chiasm, optic tract and sometimes the retrogeniculate visual pathways. It usually presents with optic nerve pallor that is typically (but not invariably) associated with decreased visual function. The key task in the evaluation is to determine whether there is an on-going process causing destruction of ganglion cells, as determining the cause may allow halting progression of vision loss, and sometimes even visual recovery. This chapter discusses how a careful neuro-ophthalmic history and exam can often establish an etiology or at least substantially narrow the differential diagnosis and guide further workup. OCT analysis can often clarify the clinical picture, and in addition may allow quantitative analysis over time. Of all diagnostic studies, neuroimaging (typically MRI with contrast) has by far the highest yield. Further testing should be performed in a directed fashion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Walsh FB. Papilledema; optic neuritis; optic atrophy. In: Walsh FB, editor. Clinical neuro-ophthalmology. Baltimore: Williams & Wilkins Co; 1947. p. 388–401.
Sadun AA, Agarwal MR. Topical diagnosis of acquired optic nerve disorders. In: Miller NR, Newman NJ, Biousse V, Kerrison JB, editors. Walsh and Hoyt’s clinical neuro-ophthalmology. 6th ed. LWW: Baltimore; 2005. p. 197–236.
Mitchell JR, Olveira C, Tsiouris AJ, Dinkin MJ. Corresponding ganglion cell atrophy in patients with postgeniculate homonymous visual field loss. J Neuroophthalmol. 2015;35:353–9.
Anderson DR. Ascending and descending optic atrophy produced experimentally in squirrel monkeys. Am J Ophthalmol. 1973;76:693–711.
Quigley HA, Anderson DR. The histologic basis of optic disk pallor in experimental optic atrophy. Am J Ophthalmol. 1977;83:709–17.
Lee AG, Chau FY, Golnik KC, et al. The diagnostic yield of the evaluation for isolated unexplained optic atrophy. Ophthalmology. 2005;112:757–9.
Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J Ophthalmol. 1989;73:960–6.
Santiesteban-Freixas R, Mendoza-Santiesteban CE, Columbie-Garbey Y, et al. Cuban epidemic optic neuropathy and its relationship to toxic and hereditary optic neuropathy. Semin Ophthalmol. 2010;25:112–22.
Wall M. Optic atrophy. Surv Ophthalmol. 1991;36:51–8.
Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol. 1994;38:427–52.
Krobel GB, Charles H, Smith RS. Granulomatous optic neuropathy. Arch Ophthalmol. 1981;99:1053–5.
Duke-Elder GI, Stewart S. System of ophthalmology. In: Neuro-ophthalmology, vol. XII. London: Kimpton; 1971.
Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478–83.
Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber hereditary optic neuropathy. Arch Ophthalmol. 1973;90:349–54.
Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145–58.
Nikoskelainen E. The clinical findings in Leber’s hereditary optic neuroretinopathy. Leber’s disease. Trans Ophthalmol Soc UK. 1985;104:845–52.
Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55:299–334.
Lessell S, Gise RL, Krobel GB. Bilateral optic neuropathy with remission in young men. Variation on a theme by Leber? Arch Neurol. 1983;40:2–6.
Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–15.
Nikoskelainen E, Sogg RL, Rosental AR, et al. The early phase in Leber hereditary optic atrophy. Arch Ophthalmol. 1977;95:969–78.
Frisen L. Fundus changes in acute malnutritional optic neuropathy. Arch Ophthalmol. 1983;101:577–9.
Stambolian D, Behrens M. Optic neuropathy associated with vitamin B12 deficiency. Am J Ophthalmol. 1977;83:465–8.
Cullom ME, Heher KL, Miller NR, et al. Leber’s hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol. 1993;111:1482–5.
Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuro-ophthalmol. 2011;31:269–78.
Greenfield DS, Siatkowski RM, Glaser JS, et al. The cupped disc. Who needs neuroimaging? Ophthalmology. 1998;105:1866–74.
DeWitt CA, Johnson LN, Schoenleber DB, et al. Visual function in patients with optic nerve pallor (optic atrophy). J Natl Med Assoc. 2003;95:394–7.
Boghen DR, Glaser JS. Ischemic optic neuropathy. Brain. 1975;98:689–708.
Drance SM. The visual field of low tension glaucoma and shock-induced optic neuropathy. Arch Ophthalmol. 1977;95:159–1361.
Fineberg E, Thompson HS. Quantitation of the afferent pupillary defect. In: Smith JL, editor. Neuro-ophthalmology focus. New York: Masson; 1979. p. 25–9.
Fraser CL, White AJR, Plant GT, Martin KR. Optic nerve cupping and the neuro-ophthalmologist. J Neuro-ophthalmol. 2013;33:377–89.
Sadun AA, Lessell S. Brightness-sense and optic nerve disease. Arch Ophthalmol. 1985;103:39–43.
Trobe JD, Glaser JS, Cassady JC. Optic atrophy: differential diagnosis by fundus observation alone. Arch Ophthalmol. 1980;98:1040–5.
Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy. Differentiation from normal tension glaucoma. Ophthalmology. 2001;108:1595–602.
Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and non-arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108:593–8.
Kanamori A, Nakamura M, Matsui N, et al. Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic discs. Ophthalmology. 2004;111:2278–83.
Jonas JB, Fernandez MC, Naumann GOH. Glaucomatous optic nerve atrophy in small discs with low cup-to-disc ratios. Ophthalmology. 1990;97:1211–5.
Quigley HA. Open-angle glaucoma. NEJM. 1993;328:1097–106.
Remo S Jr, Vessani RM. New findings in the evaluation of the optic disc in glaucoma diagnosis. Curr Opin Ophthalmol. 2007;18:122–8.
Bynke H, Holmdahl G. Megalopapilla: a differential diagnosis in suspected optic atrophy. Neuro-ophthalmology. 1981;2:53–7.
Ambati BK, Rizzo JF III. Nonglaucomatous cupping of the optic disc. Int Ophthalmol Clin. 2001;41:139–49.
Bianchi-Marzoli S, Rizzo JF III, Brancato R, Lessell S. Quantitative analysis of optic disc cupping in compressive optic neuropathy. Ophthalmology. 1995;102:436–40.
Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108:1586–94.
Danesh-Meyer H, Savino PJ, Spaeth GL, Gamble GD. Comparison of arteritis and nonarteritic anterior ischemic optic neuropathies with the Heidelberg retina tomograph. Ophthalmology. 2005;112:1104–12.
Kline LB, Glaser JS. Dominant optic atrophy. Arch Ophthalmol. 1997;97:1680–6.
Trobe JD, Glaser JS, Cassady JC, et al. Nonglaucomatous excavation of the optic disc. Arch Ophthalmol. 1980;98:1046–50.
O’Neill EC, Danesh-Meyer HV, Kong GXY, et al. Optic disc evaluation in optic neuropathies. The optic disc assessment project. Ophthalmology. 2011;118:964–70.
Torres Dias D, Ushida M, Battistella R, et al. Neurophthalmological conditions mimicking glaucomatous optic neuropathy: analysis of the most common causes of misdiagnosis. BMC Ophthamol. 2017;17:2.
Kamal D, Hitchings R. Normal tension glaucoma – a practical approach. Br J Ophthalmol. 1998;82:835–40.
Tuulonen A, Airaksinen PJ. Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression. Am J Ophthalmol. 1991;111:485–90.
Nicolela MT, Drance SM. Various glaucomatous optic nerve appearances. Clinical correlations. Ophthalmology. 1996;103:640–9.
Levin PS, Newman SA, Quigley HA, Miller NR. A clinicopathologic study of optic neuropathies associated with intracranial mass lesions with quantification of remaining axons. Am J Ophthalmol. 1983;95:295–306.
Quigley HA, Sommer A. How to use nerve fiber layer examination in the management of glaucoma. Trans Am Ophthalmol Soc. 1987;85:254–72.
Hoyt WF, Schlicke B, Eckelhoff RJ. Fundoscopic appearance of a nerve fiber bundle defect. Br J Ophthalmol. 1972;56:577–83.
Frisen L, Claesson M. Narrowing of the retinal arterioles in descending optic atrophy. A quantitative clinical study. J Ophthalmology. 1984;91:1342–6.
Duke-Elder S. System of ophthalmology. In: Diseases of the retina, vol. X. London: Kimpton; 1967. p. 577–622.
Frisen L, Hoyt WF, Tengroth BM. Optociliary veins, disc pallor and visual loss. A triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol. 1973;51:241–9.
Smith JL. Pseudohemangioma of the optic disc following ischemic optic neuropathy. J Clin Neuro-ophthalmol. 1985;5:81–9.
Friedland S, Winterkorn JMS, Burde RM. Luxury perfusion following anterior ischemic optic neuropathy. J Neuro-ophthalmol. 1996;16:163–71.
Burde RM. Optic disc risk factors for non-arteritic ischemic optic neuropathy. Am J Ophthalmol. 1993;116:759–64.
Kennedy F. Retrobulbar neuritis as an exact diagnostic sign of certain tumors and abscesses in the frontal lobe. Am J Med Sci. 1911;142:355–68.
Miller NR. Optic gliomas: past, present, and future. J Neuro-ophthalmol. 2016;36:460–73.
Moura FC, Medeiros FA, Monteiro MLR. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography. Ophthalmology. 2007;114:175–81.
Chen JJ, Kardon RH. Avoiding clinical misinterpretation and artifacts of the optical coherence tomography analysis of the optic nerve, retinal nerve fiber layer, and ganglion cell layer. J Neuro-ophthalmol. 2016;36:417–38.
Monteiro MLR, Moura FC, Medeiros FA. Diagnostic ability of optical coherence tomography with a normative database to detect band atrophy of the optic nerve. Am J Ophthalmol. 2007;143:896–9.
Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963–9.
Contreras I, Noval S, Rebolleda G, Munoz-Negrete FJ. Follow-up of nonarteritic ischemic optic neuropathy with optical coherence tomography. Ophthalmology. 2007;114:2338–44.
Kim TW, Hwang JM. Stratus OCT in dominant optic atrophy; features differentiating it from glaucoma. J Glauocoma. 2007;16:655–8.
Gupta PK, Asrani S, Freedman SF, et al. Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography. Open Neurol J. 2011;5:1–7.
Gass A, Moseley IF. The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage. J Neurol Sci. 2000;172:S17–22.
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–12.
Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78:665–71.
Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–9.
Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev. 2016;15:307–24.
Akaishi T, Sato DK, Nakashima I, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry. 2016;87(4):446–8.
Libois A, DeWit S, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis. 2007;34:141–4.
Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoantibody. Ann Neurol. 2001;49:146–54.
Stangel M, Fredrikson S, Meinl E, et al. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol. 2013;9:267–76.
Gaier ED, Boudreault K, Nakata I, et al. Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status. Mol Vis. 2017;23:548–60.
Lenaers G, Hamel C, Delettre C, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46.
Delettre-Cribaillet C, Hamel CP, Lenaers G. Optic atrophy type 1. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993-2018.2007 Jul 13 [updated 2015 Nov 12].
Allen KF, Gaier ED, Wiggs JL. Genetics of primary inherited disorders of the optic nerve: clinical applications. Cold Spring Harb Perspect Med. 2015;5:a017277.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chwalisz, B., Cestari, D.M., Borruat, FX. (2019). Workup for Optic Atrophy. In: Lee, A., Sinclair, A., Sadaka, A., Berry, S., Mollan, S. (eds) Neuro-Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-98455-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-98455-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98454-4
Online ISBN: 978-3-319-98455-1
eBook Packages: MedicineMedicine (R0)